nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ABCC4—Fluorouracil—colon cancer	0.218	0.271	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—colon cancer	0.129	0.161	CbGbCtD
Cefazolin—ABCC4—Methotrexate—colon cancer	0.12	0.149	CbGbCtD
Cefazolin—ALB—Irinotecan—colon cancer	0.084	0.105	CbGbCtD
Cefazolin—ALB—Fluorouracil—colon cancer	0.0806	0.1	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—colon cancer	0.0749	0.0934	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—colon cancer	0.0522	0.0651	CbGbCtD
Cefazolin—ALB—Methotrexate—colon cancer	0.0445	0.0554	CbGbCtD
Cefazolin—PON1—blood vessel—colon cancer	0.0235	0.287	CbGeAlD
Cefazolin—PON1—lymphoid tissue—colon cancer	0.0088	0.108	CbGeAlD
Cefazolin—PON1—bone marrow—colon cancer	0.00801	0.0979	CbGeAlD
Cefazolin—PON1—liver—colon cancer	0.00648	0.0791	CbGeAlD
Cefazolin—Superinfection—Fluorouracil—colon cancer	0.00638	0.0552	CcSEcCtD
Cefazolin—Superinfection—Capecitabine—colon cancer	0.00446	0.0386	CcSEcCtD
Cefazolin—ALB—gall bladder—colon cancer	0.00417	0.051	CbGeAlD
Cefazolin—SLC22A11—renal system—colon cancer	0.00341	0.0416	CbGeAlD
Cefazolin—TPMT—renal system—colon cancer	0.00322	0.0394	CbGeAlD
Cefazolin—SLC22A11—digestive system—colon cancer	0.00279	0.0341	CbGeAlD
Cefazolin—Local reaction—Fluorouracil—colon cancer	0.00262	0.0226	CcSEcCtD
Cefazolin—Prothrombin level increased—Capecitabine—colon cancer	0.00247	0.0213	CcSEcCtD
Cefazolin—TPMT—bone marrow—colon cancer	0.00244	0.0298	CbGeAlD
Cefazolin—Pruritus genital—Capecitabine—colon cancer	0.00242	0.021	CcSEcCtD
Cefazolin—TPMT—vagina—colon cancer	0.00233	0.0285	CbGeAlD
Cefazolin—Heartburn—Fluorouracil—colon cancer	0.0021	0.0182	CcSEcCtD
Cefazolin—SLC22A11—liver—colon cancer	0.00208	0.0254	CbGeAlD
Cefazolin—TPMT—liver—colon cancer	0.00197	0.0241	CbGeAlD
Cefazolin—ABCC4—renal system—colon cancer	0.00194	0.0237	CbGeAlD
Cefazolin—SLC22A8—renal system—colon cancer	0.00192	0.0235	CbGeAlD
Cefazolin—Blood bilirubin increased—Irinotecan—colon cancer	0.0016	0.0138	CcSEcCtD
Cefazolin—Oral candidiasis—Capecitabine—colon cancer	0.00159	0.0138	CcSEcCtD
Cefazolin—ABCC4—digestive system—colon cancer	0.00159	0.0194	CbGeAlD
Cefazolin—Nephropathy—Methotrexate—colon cancer	0.00158	0.0137	CcSEcCtD
Cefazolin—TPMT—lymph node—colon cancer	0.00151	0.0184	CbGeAlD
Cefazolin—ABCC4—bone marrow—colon cancer	0.00146	0.0179	CbGeAlD
Cefazolin—Colitis—Irinotecan—colon cancer	0.00145	0.0126	CcSEcCtD
Cefazolin—Mouth ulceration—Vincristine—colon cancer	0.0014	0.0121	CcSEcCtD
Cefazolin—ALB—liver—colon cancer	0.00122	0.0149	CbGeAlD
Cefazolin—ABCC4—liver—colon cancer	0.00118	0.0145	CbGeAlD
Cefazolin—Liver disorder—Methotrexate—colon cancer	0.00111	0.00956	CcSEcCtD
Cefazolin—Blood bilirubin increased—Capecitabine—colon cancer	0.00107	0.00926	CcSEcCtD
Cefazolin—Blood creatinine increased—Irinotecan—colon cancer	0.00103	0.0089	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00102	0.00878	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000989	0.00855	CcSEcCtD
Cefazolin—Colitis—Capecitabine—colon cancer	0.000972	0.00841	CcSEcCtD
Cefazolin—Candida infection—Capecitabine—colon cancer	0.000966	0.00836	CcSEcCtD
Cefazolin—ALB—lymph node—colon cancer	0.000938	0.0115	CbGeAlD
Cefazolin—Pancytopenia—Vincristine—colon cancer	0.000925	0.008	CcSEcCtD
Cefazolin—Mouth ulceration—Capecitabine—colon cancer	0.000915	0.00792	CcSEcCtD
Cefazolin—Neutropenia—Vincristine—colon cancer	0.000911	0.00788	CcSEcCtD
Cefazolin—ABCC4—lymph node—colon cancer	0.000908	0.0111	CbGeAlD
Cefazolin—Eosinophilia—Fluorouracil—colon cancer	0.0009	0.00778	CcSEcCtD
Cefazolin—Neutropenia—Irinotecan—colon cancer	0.000887	0.00767	CcSEcCtD
Cefazolin—Pancytopenia—Fluorouracil—colon cancer	0.000863	0.00746	CcSEcCtD
Cefazolin—Phlebitis—Capecitabine—colon cancer	0.000853	0.00738	CcSEcCtD
Cefazolin—Stomatitis—Vincristine—colon cancer	0.000847	0.00732	CcSEcCtD
Cefazolin—Hepatic function abnormal—Capecitabine—colon cancer	0.000841	0.00727	CcSEcCtD
Cefazolin—Renal failure—Irinotecan—colon cancer	0.000832	0.00719	CcSEcCtD
Cefazolin—Stomatitis—Irinotecan—colon cancer	0.000825	0.00713	CcSEcCtD
Cefazolin—Haemolytic anaemia—Capecitabine—colon cancer	0.000814	0.00704	CcSEcCtD
Cefazolin—Stomatitis—Fluorouracil—colon cancer	0.00079	0.00683	CcSEcCtD
Cefazolin—Haemoglobin—Irinotecan—colon cancer	0.000763	0.0066	CcSEcCtD
Cefazolin—Haemorrhage—Irinotecan—colon cancer	0.00076	0.00657	CcSEcCtD
Cefazolin—Agranulocytosis—Fluorouracil—colon cancer	0.000756	0.00654	CcSEcCtD
Cefazolin—Vaginal inflammation—Methotrexate—colon cancer	0.000754	0.00652	CcSEcCtD
Cefazolin—Haemoglobin—Fluorouracil—colon cancer	0.000731	0.00632	CcSEcCtD
Cefazolin—Haemorrhage—Fluorouracil—colon cancer	0.000727	0.00629	CcSEcCtD
Cefazolin—Vaginal infection—Methotrexate—colon cancer	0.000711	0.00615	CcSEcCtD
Cefazolin—Aplastic anaemia—Methotrexate—colon cancer	0.000707	0.00612	CcSEcCtD
Cefazolin—Blood creatinine increased—Capecitabine—colon cancer	0.000688	0.00595	CcSEcCtD
Cefazolin—Mouth ulceration—Methotrexate—colon cancer	0.000681	0.00589	CcSEcCtD
Cefazolin—Abdominal pain upper—Capecitabine—colon cancer	0.000671	0.0058	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000662	0.00572	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000662	0.00572	CcSEcCtD
Cefazolin—Flatulence—Irinotecan—colon cancer	0.000652	0.00563	CcSEcCtD
Cefazolin—Anaemia—Vincristine—colon cancer	0.000627	0.00543	CcSEcCtD
Cefazolin—Agitation—Vincristine—colon cancer	0.000624	0.0054	CcSEcCtD
Cefazolin—Anaemia—Irinotecan—colon cancer	0.000611	0.00529	CcSEcCtD
Cefazolin—Leukopenia—Vincristine—colon cancer	0.000608	0.00526	CcSEcCtD
Cefazolin—Pancytopenia—Capecitabine—colon cancer	0.000603	0.00522	CcSEcCtD
Cefazolin—Neutropenia—Capecitabine—colon cancer	0.000594	0.00514	CcSEcCtD
Cefazolin—Syncope—Irinotecan—colon cancer	0.000593	0.00513	CcSEcCtD
Cefazolin—Leukopenia—Irinotecan—colon cancer	0.000592	0.00512	CcSEcCtD
Cefazolin—Convulsion—Vincristine—colon cancer	0.000588	0.00509	CcSEcCtD
Cefazolin—Anaemia—Fluorouracil—colon cancer	0.000585	0.00506	CcSEcCtD
Cefazolin—Loss of consciousness—Irinotecan—colon cancer	0.000581	0.00503	CcSEcCtD
Cefazolin—Leukopenia—Fluorouracil—colon cancer	0.000567	0.0049	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000561	0.00486	CcSEcCtD
Cefazolin—Renal failure—Capecitabine—colon cancer	0.000557	0.00481	CcSEcCtD
Cefazolin—Anaphylactic shock—Vincristine—colon cancer	0.000554	0.00479	CcSEcCtD
Cefazolin—Stomatitis—Capecitabine—colon cancer	0.000552	0.00477	CcSEcCtD
Cefazolin—Convulsion—Fluorouracil—colon cancer	0.000549	0.00475	CcSEcCtD
Cefazolin—Confusional state—Irinotecan—colon cancer	0.000544	0.00471	CcSEcCtD
Cefazolin—Thrombocytopenia—Vincristine—colon cancer	0.000542	0.00469	CcSEcCtD
Cefazolin—Anaphylactic shock—Irinotecan—colon cancer	0.00054	0.00467	CcSEcCtD
Cefazolin—Shock—Irinotecan—colon cancer	0.000531	0.00459	CcSEcCtD
Cefazolin—Agranulocytosis—Capecitabine—colon cancer	0.000528	0.00457	CcSEcCtD
Cefazolin—Thrombocytopenia—Irinotecan—colon cancer	0.000528	0.00457	CcSEcCtD
Cefazolin—Anorexia—Vincristine—colon cancer	0.000528	0.00457	CcSEcCtD
Cefazolin—Confusional state—Fluorouracil—colon cancer	0.000521	0.00451	CcSEcCtD
Cefazolin—Hypotension—Vincristine—colon cancer	0.000518	0.00448	CcSEcCtD
Cefazolin—Anaphylactic shock—Fluorouracil—colon cancer	0.000517	0.00447	CcSEcCtD
Cefazolin—Anorexia—Irinotecan—colon cancer	0.000514	0.00445	CcSEcCtD
Cefazolin—Haemoglobin—Capecitabine—colon cancer	0.000511	0.00442	CcSEcCtD
Cefazolin—Hepatitis—Capecitabine—colon cancer	0.000508	0.0044	CcSEcCtD
Cefazolin—Haemorrhage—Capecitabine—colon cancer	0.000508	0.0044	CcSEcCtD
Cefazolin—Thrombocytopenia—Fluorouracil—colon cancer	0.000506	0.00438	CcSEcCtD
Cefazolin—Hypotension—Irinotecan—colon cancer	0.000504	0.00436	CcSEcCtD
Cefazolin—Anorexia—Fluorouracil—colon cancer	0.000493	0.00426	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000493	0.00426	CcSEcCtD
Cefazolin—Hypotension—Fluorouracil—colon cancer	0.000483	0.00418	CcSEcCtD
Cefazolin—Decreased appetite—Vincristine—colon cancer	0.000482	0.00417	CcSEcCtD
Cefazolin—Erythema multiforme—Capecitabine—colon cancer	0.000481	0.00416	CcSEcCtD
Cefazolin—Somnolence—Irinotecan—colon cancer	0.00048	0.00415	CcSEcCtD
Cefazolin—Fatigue—Vincristine—colon cancer	0.000478	0.00413	CcSEcCtD
Cefazolin—Dyspepsia—Irinotecan—colon cancer	0.000475	0.00411	CcSEcCtD
Cefazolin—Pain—Vincristine—colon cancer	0.000474	0.0041	CcSEcCtD
Cefazolin—Decreased appetite—Irinotecan—colon cancer	0.000469	0.00406	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—colon cancer	0.000468	0.00405	CcSEcCtD
Cefazolin—Fatigue—Irinotecan—colon cancer	0.000465	0.00402	CcSEcCtD
Cefazolin—Pain—Irinotecan—colon cancer	0.000461	0.00399	CcSEcCtD
Cefazolin—Somnolence—Fluorouracil—colon cancer	0.000459	0.00397	CcSEcCtD
Cefazolin—Dyspepsia—Fluorouracil—colon cancer	0.000455	0.00393	CcSEcCtD
Cefazolin—Gastrointestinal pain—Vincristine—colon cancer	0.000453	0.00392	CcSEcCtD
Cefazolin—Decreased appetite—Fluorouracil—colon cancer	0.000449	0.00389	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—colon cancer	0.000449	0.00388	CcSEcCtD
Cefazolin—Feeling abnormal—Irinotecan—colon cancer	0.000445	0.00385	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—colon cancer	0.000442	0.00382	CcSEcCtD
Cefazolin—Pain—Fluorouracil—colon cancer	0.000442	0.00382	CcSEcCtD
Cefazolin—Gastrointestinal pain—Irinotecan—colon cancer	0.000441	0.00382	CcSEcCtD
Cefazolin—Abdominal pain—Vincristine—colon cancer	0.000438	0.00379	CcSEcCtD
Cefazolin—Body temperature increased—Vincristine—colon cancer	0.000438	0.00379	CcSEcCtD
Cefazolin—Flatulence—Capecitabine—colon cancer	0.000436	0.00377	CcSEcCtD
Cefazolin—Body temperature increased—Irinotecan—colon cancer	0.000427	0.00369	CcSEcCtD
Cefazolin—Abdominal pain—Irinotecan—colon cancer	0.000427	0.00369	CcSEcCtD
Cefazolin—Feeling abnormal—Fluorouracil—colon cancer	0.000426	0.00368	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000418	0.00361	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—colon cancer	0.000414	0.00358	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—colon cancer	0.000411	0.00355	CcSEcCtD
Cefazolin—Urticaria—Fluorouracil—colon cancer	0.000411	0.00355	CcSEcCtD
Cefazolin—Anaemia—Capecitabine—colon cancer	0.000409	0.00354	CcSEcCtD
Cefazolin—Body temperature increased—Fluorouracil—colon cancer	0.000409	0.00353	CcSEcCtD
Cefazolin—Hypersensitivity—Vincristine—colon cancer	0.000408	0.00353	CcSEcCtD
Cefazolin—Hypersensitivity—Irinotecan—colon cancer	0.000398	0.00344	CcSEcCtD
Cefazolin—Asthenia—Vincristine—colon cancer	0.000398	0.00344	CcSEcCtD
Cefazolin—Syncope—Capecitabine—colon cancer	0.000397	0.00343	CcSEcCtD
Cefazolin—Leukopenia—Capecitabine—colon cancer	0.000396	0.00343	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—colon cancer	0.000393	0.0034	CcSEcCtD
Cefazolin—Loss of consciousness—Capecitabine—colon cancer	0.000389	0.00336	CcSEcCtD
Cefazolin—Asthenia—Irinotecan—colon cancer	0.000387	0.00335	CcSEcCtD
Cefazolin—Hypersensitivity—Fluorouracil—colon cancer	0.000381	0.00329	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—colon cancer	0.00038	0.00329	CcSEcCtD
Cefazolin—Diarrhoea—Vincristine—colon cancer	0.000379	0.00328	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—colon cancer	0.000378	0.00327	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—colon cancer	0.000378	0.00327	CcSEcCtD
Cefazolin—Diarrhoea—Irinotecan—colon cancer	0.000369	0.00319	CcSEcCtD
Cefazolin—Dizziness—Vincristine—colon cancer	0.000366	0.00317	CcSEcCtD
Cefazolin—Pruritus—Fluorouracil—colon cancer	0.000366	0.00316	CcSEcCtD
Cefazolin—Confusional state—Capecitabine—colon cancer	0.000364	0.00315	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—colon cancer	0.000358	0.00309	CcSEcCtD
Cefazolin—Dizziness—Irinotecan—colon cancer	0.000357	0.00309	CcSEcCtD
Cefazolin—Shock—Capecitabine—colon cancer	0.000355	0.00307	CcSEcCtD
Cefazolin—Diarrhoea—Fluorouracil—colon cancer	0.000354	0.00306	CcSEcCtD
Cefazolin—Thrombocytopenia—Capecitabine—colon cancer	0.000354	0.00306	CcSEcCtD
Cefazolin—Vomiting—Vincristine—colon cancer	0.000352	0.00305	CcSEcCtD
Cefazolin—Rash—Vincristine—colon cancer	0.000349	0.00302	CcSEcCtD
Cefazolin—Dermatitis—Vincristine—colon cancer	0.000349	0.00302	CcSEcCtD
Cefazolin—Headache—Vincristine—colon cancer	0.000347	0.003	CcSEcCtD
Cefazolin—Anorexia—Capecitabine—colon cancer	0.000344	0.00298	CcSEcCtD
Cefazolin—Vomiting—Irinotecan—colon cancer	0.000343	0.00297	CcSEcCtD
Cefazolin—Dizziness—Fluorouracil—colon cancer	0.000342	0.00296	CcSEcCtD
Cefazolin—Rash—Irinotecan—colon cancer	0.00034	0.00294	CcSEcCtD
Cefazolin—Dermatitis—Irinotecan—colon cancer	0.00034	0.00294	CcSEcCtD
Cefazolin—Headache—Irinotecan—colon cancer	0.000338	0.00292	CcSEcCtD
Cefazolin—Hypotension—Capecitabine—colon cancer	0.000337	0.00292	CcSEcCtD
Cefazolin—Nausea—Vincristine—colon cancer	0.000329	0.00285	CcSEcCtD
Cefazolin—Vomiting—Fluorouracil—colon cancer	0.000329	0.00284	CcSEcCtD
Cefazolin—Rash—Fluorouracil—colon cancer	0.000326	0.00282	CcSEcCtD
Cefazolin—Dermatitis—Fluorouracil—colon cancer	0.000326	0.00282	CcSEcCtD
Cefazolin—Headache—Fluorouracil—colon cancer	0.000324	0.0028	CcSEcCtD
Cefazolin—Nausea—Irinotecan—colon cancer	0.000321	0.00277	CcSEcCtD
Cefazolin—Dyspepsia—Capecitabine—colon cancer	0.000318	0.00275	CcSEcCtD
Cefazolin—Decreased appetite—Capecitabine—colon cancer	0.000314	0.00272	CcSEcCtD
Cefazolin—Fatigue—Capecitabine—colon cancer	0.000311	0.00269	CcSEcCtD
Cefazolin—Pain—Capecitabine—colon cancer	0.000309	0.00267	CcSEcCtD
Cefazolin—Nausea—Fluorouracil—colon cancer	0.000307	0.00265	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—colon cancer	0.000304	0.00263	CcSEcCtD
Cefazolin—Feeling abnormal—Capecitabine—colon cancer	0.000298	0.00257	CcSEcCtD
Cefazolin—Gastrointestinal pain—Capecitabine—colon cancer	0.000295	0.00255	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—colon cancer	0.000295	0.00255	CcSEcCtD
Cefazolin—Urticaria—Capecitabine—colon cancer	0.000287	0.00248	CcSEcCtD
Cefazolin—Abdominal pain—Capecitabine—colon cancer	0.000285	0.00247	CcSEcCtD
Cefazolin—Body temperature increased—Capecitabine—colon cancer	0.000285	0.00247	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—colon cancer	0.000285	0.00247	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—colon cancer	0.000271	0.00234	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—colon cancer	0.000269	0.00233	CcSEcCtD
Cefazolin—Hypersensitivity—Capecitabine—colon cancer	0.000266	0.0023	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—colon cancer	0.000263	0.00228	CcSEcCtD
Cefazolin—Asthenia—Capecitabine—colon cancer	0.000259	0.00224	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—colon cancer	0.000256	0.00222	CcSEcCtD
Cefazolin—Pruritus—Capecitabine—colon cancer	0.000256	0.00221	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—colon cancer	0.000251	0.00217	CcSEcCtD
Cefazolin—Diarrhoea—Capecitabine—colon cancer	0.000247	0.00214	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—colon cancer	0.000239	0.00207	CcSEcCtD
Cefazolin—Dizziness—Capecitabine—colon cancer	0.000239	0.00207	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—colon cancer	0.000237	0.00205	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—colon cancer	0.000234	0.00202	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—colon cancer	0.000232	0.002	CcSEcCtD
Cefazolin—Pain—Methotrexate—colon cancer	0.00023	0.00199	CcSEcCtD
Cefazolin—Vomiting—Capecitabine—colon cancer	0.00023	0.00199	CcSEcCtD
Cefazolin—Rash—Capecitabine—colon cancer	0.000228	0.00197	CcSEcCtD
Cefazolin—Dermatitis—Capecitabine—colon cancer	0.000227	0.00197	CcSEcCtD
Cefazolin—Headache—Capecitabine—colon cancer	0.000226	0.00196	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—colon cancer	0.000222	0.00192	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—colon cancer	0.00022	0.0019	CcSEcCtD
Cefazolin—Nausea—Capecitabine—colon cancer	0.000215	0.00186	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—colon cancer	0.000214	0.00185	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—colon cancer	0.000213	0.00184	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—colon cancer	0.000213	0.00184	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—colon cancer	0.000198	0.00171	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—colon cancer	0.000193	0.00167	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—colon cancer	0.00019	0.00165	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—colon cancer	0.000184	0.00159	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—colon cancer	0.000178	0.00154	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—colon cancer	0.000171	0.00148	CcSEcCtD
Cefazolin—Rash—Methotrexate—colon cancer	0.00017	0.00147	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—colon cancer	0.000169	0.00146	CcSEcCtD
Cefazolin—Headache—Methotrexate—colon cancer	0.000168	0.00146	CcSEcCtD
Cefazolin—Nausea—Methotrexate—colon cancer	0.00016	0.00138	CcSEcCtD
